Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Contribution of Arab Countries to Oncology Clinical Trials: A Bibliometric Analysis

Version 1 : Received: 20 June 2023 / Approved: 21 June 2023 / Online: 21 June 2023 (12:53:49 CEST)

A peer-reviewed article of this Preprint also exists.

Al-Shamsi, H.O.; Abu-Gheida, I.; Sameh, K.; Tahoun, N.E.; Musallam, K.M. Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis. Cancers 2023, 15, 4428. Al-Shamsi, H.O.; Abu-Gheida, I.; Sameh, K.; Tahoun, N.E.; Musallam, K.M. Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis. Cancers 2023, 15, 4428.

Abstract

The increasing cancer burden is a major health concern in Arab countries with variations in cancer profiles. Given the limited oncology research output and scarce data on cancer trial participation in the Arab region, this study explored the therapeutic cancer trial landscape in Arab countries over the past 20 years. A bibliometric analysis of the PubMed database was conducted on primary publications of therapeutic trials with a participating Arab center. Arab countries participated in 320 published cancer-related therapeutic trials (2000‒2021). There was a consistent increase in the number of trials, sample size, multiregional site participation, and number of randomized trials. However, most trials were small, did not receive external funding, and included a single Arab site. Compared with Arab-only trials, trials with joint non-Arab sites were larger (p = .003) and more likely to be externally funded (p < .001). Citation numbers and journal impact factors were higher in trial publications with joint non-Arab authorship than those without (p < .001, for both). Despite improving conduct and publication records of oncology trials with Arab centers, cancer trial participation remains limited in Arab countries. Concerted efforts are required to encourage sponsorship and international collaboration in this region.

Keywords

research; oncology; Arab; Middle East; North Africa; cancer management

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.